Abstract

Human growth and development occur as a result of numerous processes which gets initiated under the influence of endocrine hormones. Insulin-like growth factor 1 (IGF-1) plays a most pivotal role in the growth and organ development of a child. IGF-1 is a peptide that belongs to somatomedins group of hormones, also known as somatomedin C. It releases from the liver and other tissues under the influence of growth hormone (GH). The liver is the main protagonist source of IGF-1 hence any disease that can cause liver dysfunction will eventually lead to growth impairment. During the period of growth regulation with GH therapy in liver disease and/or post liver transplantation, the persistent deficiency of IGF-1 proves to be a big challenge to therapy. Growth hormone therapy together with IGF-1 infusion can lead to good results on growth. Therefore, it is important to focus on IGF- level in serum along with Growth hormone while treating a child with poor growth in chronic liver disease and after liver transplantation. The role of IGF-1 therapy should also be considered for better growth and development.


References

1. Clemmons DR, Snyder PJ, Martin A. Physiology of insulin-like growth factor 1 2016 UpToDate. Available from: https://www.uptodate.com/contents/physiology-of-insulin-like-growth-factor-1.
2. Höppener, J. W. M., et al. "The human gene encoding insulin-like growth factor I is located on chromosome 12." Human genetics 69.2 (1985): 157-160.
3. Salmon WD, Daughaday WH 1957 A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49:825–826.
4. Froesch ER, Burgi H, Ramseier EB, et al. Antibody-suppressible and nonsuppressible insulin-like activities in human serum and their physiologic significance. An insulin assay with adipose tissue of increased precision and specificity. J Clin Invest 1963;42:1816–34.
5. Yakar S, Courtland H-W, Clemmons D. IGF-1 and Bone: New Discoveries From Mouse Models. Journal of Bone and Mineral Research. 2010;25(12):2543-2552. doi:10.1002/jbmr.234.
6. Clemmons, David R. "Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer." Nature reviews Drug discovery 6.10 (2007): 821-833.
7. Melmed S, Polonsky KP, Larsen RP, Kronenberg HM. 13th Edition, Williams Textbook of Endocrinology. Elsevier Publication.
8. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 2003; 13:113.
9. Norat, T.; Dossus, L.; Rinaldi, S.; Overvad, K.; Grønbaek, H.; Tjønneland, A.; Olsen, A.; Clavel-Chapelon, F.; Boutron-Ruault, M.C.; Boeing, H.; et al. Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur.J.Clin. Nutr. 2007, 61, 91–98.
10. Clark RG, Robinson IC: Up and down the growth hormone cascade. Cytokine Growth Factor Rev 7:65 -80, 1996.
11. Kandemir N, Yordam N, Oguz H. Age-related differences in serum insulin-like growth factor-I (IGF-I) and IGFbinding protein-3 levels in congenital hypothyroidism. J Pediatr Endocrinol Metab 1997;10:379-385.
12. Guha, Sönksen & Holt (2009): IGF-I abuse in sport: Current knowledge and future prospects for detection. Growth Hormone & IGF Research 19: 408–41-1.
13. Daughaday WH, Rotwein P: Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10:68 -91, 1989.
14. Le Roith D. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. The New England journal of medicine. 1997 Feb;336(9):633-40.
15. Le Roith D. Insulin-like growth factors. New England Journal of Medicine. 1997 Feb 27;336(9):633-40.
16. Gluckman, P. D., et al. "Asphyxial brain injury—the role of the IGF system." Molecular and cellular endocrinology 140.1 (1998): 95-99.
17. Niblock MM, Brunso-Bechtold JK, Riddle DR. Insulin-like growth factor I stimulates dendritic growth in primary somatosensory cortex. The Journal of Neuroscience. 2000 Jun 1;20(11):4165-76.
18. Stratikopoulos E, Szabolcs M, Dragatsis I, et al. The hormonal action of IGF1 in postnatal mouse growth. Proc Natl Acad Sci U S A 2008; 105:19378.
19. Rozario KS, Lloyd C, Ryan F. Gh and Igf-1 Physiology in Childhood. [Updated 2015 Nov 20]. In: De Groot LJ, Beck-Peccoz P, Chrousos G, et al., editors. Endotext [Internet]. South Dartmouth (MA): Available from: http://www.ncbi.nlm.nih.gov/books/NB343487/
20. Merimee TJ, Zapf J, Froesch ER. Dwarfism in the pygmy. An isolated deficiency of insulin-like growth factor I. N Engl J Med. 1981;305:965–968.
21. Journal of Clinical Investigation. "The hormone IGF-1: A trigger of puberty." ScienceDaily. ScienceDaily, 26 July 2010. Available at www.sciencedaily.com/releases/2010/07/100712121826.htm
22. Van Dam, P. S., et al. "Growth hormone, insulin-like growthfactor I and cognitive function in adults." Growth Hormone & IGF Research 10 (2000): S69-S73.
23. Webb EA, O'Reilly MA, Clayden JD, et al. Effect of growth hormone deficiency on brain structure, motor function and cognition. Brain. 2012;135(1):216–227.
24. Chin E, Zhou J, Dai J, Baxter RC, Bondy CA: Cellular localization and regulation of gene expression for components of the insulin like growth factor tertiary binding protein complex. Endocrinology 1994,134(6):2498–2504.
25. Donaghy AJ, Delhanty PJ, Ho KK, Williams R, Baxter RC. Regula-tion of the growth rormone receptor/binding protein, insulin-like growth factor tetianary complex system in human cirrhosis. J Hepatol. 2002;36(6):751-8.
26. Soliman AT, El Banna N, Ansari BM. GH response to provocation and circulating IGF-I and IGF-binding protein-3 concentrations, the IGF-I generation test and clinical response to GH therapy in children with beta-thalassaemia. Eur J Endocrinol. 1998;138:394–400.
27. Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, et al. Bone mineral density, serum insulin like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology1998;28:695–9.
28. Greer RM, Quirk P, Cleghorn GJ, Shepherd RW. Growth hormone resistance and somatomedins in children with end-stage liver disease awaiting transplantation. J Pediatr Gastroenterol Nutr. 1998 Aug. 27(2):148-54
29. Bartosh SM, Thomas SE, Sutton MM, et al. linear growth after pediatric liver transplantation. J Pediatr 1999;135:624-631.
30. Hardin DS, Ferkol T, Ahn C, Dreimane D, Dyson M,Mors e M, Prestidge C, RiceJ, Seilheime r DK. A retrospective study of growth hormone use in adolescents with cystic fibrosis. Clin Endocrinol (Oxf) 2005; 62:560-566.
31. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J Clin Invest 1993; 91:391.
32. Rosenbloom AL (2007). "The role of recombinant insulin-like growth factor I in the treatment of the short child". Curr. Opin. Pediatr. 19 (4): 458–64.
33. Mehta V, Bhat A. Health awareness and behavior among adolescent students in a rural school: a cross sectional observational study. Int J Res Med Sci. 2015; 3(12): 3499-3502.doi:10.18203/2320-6012.ijrms20151231

Comments & Peer Review


Must Read